Expression of β-adrenergic receptor up-regulation is mediated by two different processes

Brain Research

Volumn 1112, Issue 1, 2006, Pages 114-125

  Ohkuma, Seitaro ^a   Katsura, Masashi ^a   Shibasaki, Masahiro ^a   Tsujimura, Atsushi ^b   Hirouchi, Masaaki ^c  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

adrenergic receptor; 3H CGP 12177 binding; Cerebrocortical neuron; Nadolol; Up regulation

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 AMINOBUTYRIC ACID A RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOHEXIMIDE; DACTINOMYCIN; MESSENGER RNA; METOPROLOL; MUSCARINIC RECEPTOR; NADOLOL; TRITIUM;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOSOL; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; DRUG RECEPTOR BINDING; MOUSE; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

ADRENERGIC BETA-ANTAGONISTS; ALPRENOLOL; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CEREBRAL CORTEX; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO; EMBRYO, MAMMALIAN; MICE; NADOLOL; NEURONS; PROPANOLAMINES; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRITIUM; UP-REGULATION;

EID: 33748431059     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.06.107     Document Type: Article

References (60)

1. Aarons R.D., and Molinoff P.B. Changes in the density of β-adrenergic receptor in rat lymphocytes, heart and lung after chronic treatment with propranolol. J. Pharmacol. Exp. Ther. 221 (1982) 439-443
2. Aarons R.D., Nies A.S., Gal J., Hegstrand L.R., and Molinoff P.B. Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration. J. Clin. Invest. 65 (1980) 949-957
3. Ackerman J.M., Womble M.D., and Moises H.C. Multiple effects of long-term morphine treatment on postsynaptic β-adrenergic receptor function in hippocampus: an intracellular analysis. Brain Res. 656 (1994) 309-318
4. Bermak J.C., and Zhou Q.-Y. Accessory proteins in the biogenesis of G protein-coupled receptors. Mol. Interv. 1 (2001) 282-287
5. Bernard V., Décossas M., Liste I., and Bloch B. Intraneuronal trafficking of G-protein-coupled receptors in vivo. Trends Neurosci. 29 (2006) 140-147
6. 1-adrenergic receptor genomic clone. DNA Cell Biol. 12 (1993) 537-547
7. 2-adrenergic receptor gene in response to short-term agonist exposure. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 4853-4857
8. 1-adrenergic receptor 5′-flanking promotor region. Biochim. Biophys. Acta 1172 (1993) 171-174
9. Danner S., and Lohse M.J. Regulation of β-adrenergic receptor responsiveness. Modulation of receptor gene expression. Rev. Physiol. Biochem. Pharmacol. 136 (1999) 183-223
10. 1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J. Neurosci. 21 (2001) 5546-5558
11. 2 dopamine receptors in the rat caudate putamen. Br. J. Pharmacol. 123 (1998) 833-838
12. Emillien G., and Maloteaux J.-M. Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists. Eur. J. Clin. Pharmacol. 53 (1998) 389-404
13. 2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther. 271 (1994) 1574-1582
14. Fleming W., and Westfall D.P. Adaptive supersensitivity. Handbook of Experimental Pharmacology. Catecholamine vol. 9 (1988), Springer-Verlag, Heiderberg
15. Fukamauchi F., Saunders P.A., Hough C., and Chuang D.-M. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. Mol. Pharmacol. 44 (1993) 940-949
16. i coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J. Neurochem. 72 (1999) 282-291
17. Glaubiger G., and Lefkowitz R.J. Elevated β-AR number after chronic propranolol treatment. Biochem. Biophys. Res. Commun. 78 (1977) 720-725
18. 1-adrenergic receptor. Am. J. Physiol. Endocrinol. Metab. 43 (2001) E199-E202
19. Harden T.K., Petch L.A., Traynelis S.F., and Waldo G.L. Agonist-induced alteration in the membrane form of muscarinic cholinergic receptors. J. Biol. Chem. 260 (1985) 13060-13066
20. Hedbergm A., Cerber J.G., Nies A.S., Wolf B.B., and Molinoff P.B. Effect of pindolol and propranolol on β-adrenergic receptors on human lymphocytes. J. Pharmacol. Exp. Ther. 293 (1986) 117-123
21. Hill S. G-protein-coupled receptors: past, present and future. Br. J. Pharmacol. 147 (2006) S27-S37
22. Kato T. Sequence analysis of twenty mouse brain cDNA clones selected by specific expression patterns. J. Neurosci. 2 (1991) 704-711
23. Katsura M., Ohkuma S., Tsujimura A., and Kuriyama K. Increase of diazepam bindings inhibitor mRNA levels in the brains of chronically ethanol-treated and -withdrawn mice. J. Pharmacol. Exp. Ther. 273 (1995) 1529-1533
24. Katsura M., Ohkuma S., Jun X., and Kuriyama K. Down-regulation of benzodiazepine receptors by ethyl-β-carboline-3-carboxylate in cerebrocortical neurons. Eur. J. Pharmacol. 298 (1996) 71-77
25. Kaumann A.J. Four β-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol. Sci. 18 (1997) 70-76
26. Koenig J.A., and Edwardson J.M. Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol. Sci. 18 (1997) 276-287
27. Krum H., and Pillay P. β-Adrenoceptor blocking agents. Med. J. Aust. 168 (1998) 232-235
28. Kuriyama K., Tomono S., Kishi M., Mukainaka T., and Ohkuma S. Development of γ-aminobutyric acid (GABA)ergic neurons in cerebral cortical neurons in primary culture. Brain Res. 416 (1987) 7-21
29. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
30. Leng Y., Chase T.N., and Bennett M.C. Muscarinic receptor stimulation induces translocation of an alpha-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasma. J. Biol. Chem. 276 (2001) 28212-28218
31. 1-adrenergic receptor mRNA and density but not signaling in neonatal rat cardiac myocytes. Circulation 94 (1996) 3303-3310
32. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-2275
33. Luttrell L.M., and Lefkowitz R.J. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115 (2002) 455-465
34. Ma F.-H., Ohkuma S., Kishi M., and Kuriyama K. Ontogeny of β-adrenergic receptor-mediated cyclic AMP generating system in primary cultured neurons. Int. J. Dev. Neurosci. 9 (1991) 347-356
35. 2-adrenoceptor by sustained treatment with inverse agonists but not antagonists. FEBS Lett. 399 (1996) 108-112
36. 2-adrenergic receptor gene are obligate for glucocorticoid regulation of receptor mRNA levels. Biochim. Biophys. Res. Commun. 154 (1988) 676-681
37. 2-adrenergic receptor gene. Biochim. Biophys. Acta 1305 (1996) 135-138
38. Michel T., and Weinfeld M.S. Coronary Artery Diseases: Melmon and Morrelli's Clinical Pharmacology. 5th ed. (2000), McGraw-Hill Companies, Inc., New York, USA
39. 2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment. Br. J. Pharmacol. 94 (1988) 685-692
40. Nakada M.T., Haskell K.M., Ecker D.J., Stadel J.M., and Crookes S.T. Genetic regulation of β-2-adrenergic receptors in 3T3-L1 fibroblasts. Biochem. J. 260 (1989) 53-59
41. Ohkuma S., Kishi M., Ma F.-H., and Kuriyama K. Alterations in receptor-coupled second messenger systems at up-regulated muscarinic receptors: analysis using primary cultured neurons. Eur. J. Pharmacol. 189 (1990) 277-285
42. 2+ influx through voltage-dependent calcium channels. J. Neurochem. 76 (2001) 341-350
43. 1-adrenergic receptor gene. Psychiatry Clin. Neurosci. 52 (1998) 453-458
44. 1-adrenergic receptor gene. Biochem. Biophys. Res. Commun. 211 (1995) 254-261
45. Papp M., Nalepa I., and Vetulani J. Reversal by imipramine of β-adrenoceptor up-regulation induced in a chronic mild stress model of depression. Eur. J. Pharmacol. 261 (1994) 141-147
46. Ponte P., Ng S.Y., Engel J., Gunning F., and Kedas L. Evolutionary conservation in the untranslated regions on actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res. 12 (1984) 1687-1691
47. Riva M.A., and Creese I. Reevaluation of the regulation of β-adrenergic receptor bindings by desipramine treatment. Mol. Pharmacol. 36 (1989) 211-218
48. Ruedrich S., and Erhardt L. Beta-adrenergic blockers in mental retardation and developmental disorders. MRDD Res. Rev. 5 (1999) 290-298
49. Searles R.P., Nipper V.J., and Machida C.A. The rhesus macque beta1-adrenergic receptor gene: structure of the gene and comparison of the flanking sequences with the rat beta1-adrenergic receptor gene. DNA Seq. 4 (1994) 231-241
50. 1-adrenergic receptor gene: characterization of the transcript and identification of important sequences. J. Biol. Chem. 270 (1995) 157-162
51. Shimomura H., and Terada A. Primary structure of the rat beta-1 adrenergic receptor gene. Nucleic Acid Res. 18 (1990) 4591-4598
52. 2 receptor mRNA in rat brain. J. Mol. Neurosci. 2 (1990) 155-161
53. Staehelin M., Simons P., Jaegg K., and Wigger N. CGP-12177. A hydrophilic β-adrenergic receptor radioligand reveals high affinity bindings of agonists to intact cells. J. Biol. Chem. 258 (1983) 3496-3502
54. 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 18 (1997) 70-78
55. Strulovici B., and Lefkowitz R.J. Activation, desensitization, and recycling of frog erythrocyte β-adrenergic receptors. J. Biol. Chem. 259 (1984) 4389-4395
56. Tan C.M., Brady A.E., Nickols H.H., Wang Q., and Limbird L.E. Membrane trafficking of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 559-609
57. Tsao P.I., and von Zastrow M. Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors. Pharmacol. Ther. 89 (2001) 139-147
58. 3H-CGP12177 to β-adrenoceptors in rat myocardial membranes. Jpn. J. Pharmacol. 49 (1989) 11-19
59. Waldo G.L., Northup J.K., Perkins J.P., and Harden T.K. Characterization of an altered membrane form of the β-adrenergic receptor produced during agonist-induced desensitization. J. Biol. Chem. 258 (1983) 13900-13908
60. Wolff B.B., Harden T.K., Sporn J.R., and Molinoff P.B. Presynaptic modulation of β-adrenergic receptor in rat cerebral cortex after treatment with antidepressants. J. Pharmacol. Exp. Ther. 207 (1978) 446-457